BDBM50161693 3-(5-Chloro-thiazol-2-yl)-1-(4-methanesulfonyl-phenyl)-1-(tetrahydro-furan-2-ylmethyl)-urea::CHEMBL180858
SMILES: CS(=O)(=O)c1ccc(cc1)N(CC1CCCO1)C(=O)Nc1ncc(Cl)s1
InChI Key: InChIKey=ZEGOFTZQNGADRL-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hexokinase type IV (Rattus norvegicus) | BDBM50161693 (3-(5-Chloro-thiazol-2-yl)-1-(4-methanesulfonyl-phe...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | Article PubMed | n/a | n/a | n/a | n/a | 2.16E+4 | n/a | n/a | n/a | n/a |
OSI Pharmaceuticals Curated by ChEMBL | Assay Description Effective concentration for glucokinase activation with 5 mM glucose | Bioorg Med Chem Lett 15: 1501-4 (2005) Article DOI: 10.1016/j.bmcl.2004.12.083 BindingDB Entry DOI: 10.7270/Q2HT2NVC | |||||||||||
More data for this Ligand-Target Pair |